Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.25.4
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Sep. 29, 2024 $ 7 $ 21,465 $ (2,664) $ 18,808
Balance, Shares at Sep. 29, 2024 6,873,938      
Stock Compensation Expense 92 92
Restricted Board Shares Issued [1]
Restricted Board Shares Issued, shares [1] 22,800      
Net Income 844 844
Balance at Dec. 29, 2024 $ 7 21,557 (1,820) 19,744
Balance, Shares at Dec. 29, 2024 6,896,738      
Balance at Sep. 28, 2025 $ 7 21,801 2,483 24,291
Balance, Shares at Sep. 28, 2025 6,920,658      
Stock Compensation Expense 212 212
Restricted Board Shares Issued [2]
Restricted Board Shares Issued, shares [2] 16,700      
Net Income 242 242
Balance at Dec. 28, 2025 $ 7 $ 22,013 $ 2,725 $ 24,745
Balance, Shares at Dec. 28, 2025 6,937,358      
[1] Restricted Share Grant on November 5, 2024 to independent board members of 7,600 shares each, which vested on January 1, 2026
[2] Restricted Share Grant on November 4, 2025 to independent board members of 4,000 shares each, and December 5, 2025 of 4,700 shares to Danny Schoening, which will vest on January 1, 2027.